Less than one in ten Phase III clinical trials are ever cited at the point-of-care
A decade-long analysis reveals potential bottlenecks in the pathway of clinical research into medical practice. Cambridge, UK – [12:30pm / Feb 28] – A study has characterised the factors [...]